TRIS

ANGUS To Expand U.S. Manufacturing Capacity For TRIS AMINO™ Tromethamine Buffers

Thursday, October 14, 2021 - 2:00pm

BUFFALO GROVE, Ill., Oct. 14, 2021 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty ingredients and consumables for biotechnology, pharmaceutical, consumer and industrial applications, today announced plans to expand U.S. production capacity for its complete portfolio of TRIS AMINO tromethamine buffers.

Key Points: 
  • BUFFALO GROVE, Ill., Oct. 14, 2021 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty ingredients and consumables for biotechnology, pharmaceutical, consumer and industrial applications, today announced plans to expand U.S. production capacity for its complete portfolio of TRIS AMINO tromethamine buffers.
  • The planned expansion includes the addition of a fourth dedicated manufacturing line at ANGUS' existing facility in Sterlington, Louisiana, and will roughly double the Company's global TRIS AMINO buffer production capacity.
  • Today, the company produces high-purity, multi-compendial grades of TRIS AMINO products for the life sciences and personal care markets at its Sterlington and recently expanded Ibbenbren, Germany manufacturing facilities.
  • Between 2016 and 2021, ANGUS doubled TRIS AMINO production capacity.

Tristar Acquisition I Corp. Announces Pricing of $200 Million Initial Public Offering

Wednesday, October 13, 2021 - 11:00pm

ATLANTA, Oct. 13, 2021 /PRNewswire/ -- Tristar Acquisition I Corp. (the "Company"), today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.

Key Points: 
  • ATLANTA, Oct. 13, 2021 /PRNewswire/ -- Tristar Acquisition I Corp. (the "Company"), today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.
  • The Company has granted the underwriters a 45-day option to purchase up to 3,000,000 additional units at the initial public offering price to cover over-allotments, if any.
  • This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds thereof.
  • The Tristar management team and board combines extensive telecom industry experience with deep expertise in mergers and acquisitions.

ANGUS Appoints Biopharma Executive Julie O'Neill To Board Of Directors

Wednesday, October 6, 2021 - 2:00pm

BUFFALO GROVE, Ill., Oct. 6, 2021 /PRNewswire/ --ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty ingredients for biotechnology, pharmaceutical, consumer and industrial applications, today announced the appointment of Julie O'Neill to the Company's Board of Directors.

Key Points: 
  • BUFFALO GROVE, Ill., Oct. 6, 2021 /PRNewswire/ --ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty ingredients for biotechnology, pharmaceutical, consumer and industrial applications, today announced the appointment of Julie O'Neill to the Company's Board of Directors.
  • O'Neill is a results-driven biopharmaceutical executive, with more than two decades of leadership experience and currently serves on the board of several leading life sciences companies.
  • "We are thrilled to welcome Julie to our board.
  • "I am delighted to join the Board of Directors of ANGUS," said O'Neill.